We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Downregulation of Tumor Suppressor Gene Spurs Development of Ovarian Cancer

By LabMedica International staff writers
Posted on 28 Feb 2012
Researchers studying ovarian cancer have identified a tumor suppressor gene that has significantly lowered expression in ovarian cancer cells, and which may be a useful diagnostic and therapeutic marker for the disease.

Investigators at the Medical University of Vienna (Austria) focused on the hVps37A gene which produces a protein described as a member of the membrane-trafficking ESCRT-I (endosomal sorting complex required for transport-I) complex that mediates the internalization and degradation of ubiquitinated membrane receptors.

In the current study, the investigators used a tetracycline inducible ovarian cancer cell-culture model to show the effects of hVps37A knockdown in vitro and in vivo. More...
In addition, they studied the effects of the epidermal growth factor receptor (EGFR) inhibitors cetuximab and lapatinib on ovarian cancer cells under conditions of hVps37A knockdown.

Results published in the December 15, 2011, edition of the journal Clinical Cancer Research revealed that hVps37A was significantly downregulated in ovarian cancer and modified the prognostic value of EGFR and HER2 (human epidermal growth factor receptor 2) expression. In addition, hVps37A downregulation in ovarian cancer cells led to cytoplasmic EGFR retention and hyperactivation of downstream pathways and was associated with enhanced xenograft growth in nude mice and invasion of the collagen matrix. In other words, the activated form of EGFR was not degraded and continued to affect greatly subsequent cellular processes - something that hVps37A would have inhibited. Furthermore, hVps37A-deficient cells became irresponsive to inhibition by the therapeutic antibody cetuximab.

Senior author Dr. Michael Krainer, professor of oncology at the Medical University of Vienna, said, “Our results, which are based on an unparalleled number of tissue samples from ovarian cancer, clearly confirm a significant reduction of hVps37A activity. At the same time, we found that this reduced activity strongly influences the activity of the membrane receptor EGFR. This is an essential indication of the function of hVps37A - and of the importance of our results for other cancer types, in which EGFR activity causes cancer to develop.”

Related Links:
Medical University of Vienna



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Aspiration System
VACUSAFE
New
Portable POCT Blood Gas Analyzer
BD100
New
MR-proADM Test
B•R•A•H•M•S MR-proADM KRYPTOR test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: 123RF

Screening After Pneumococcal Disease May Reveal Undiagnosed Blood Cancer or Immune Disorders

Severe pneumococcal disease requiring hospitalization often presents as pneumonia, particularly in older adults and people with cancer or compromised immune function. Because M protein testing and antibody... Read more

Microbiology

view channel
Image Credit: 123RF

FDA-Cleared Multiplex PCR Test Detects 13 Respiratory Pathogens in a Single Sample

Respiratory tract infections can be difficult to distinguish at presentation because many cause overlapping, nonspecific symptoms and are initially grouped as influenza-like illnesses. Causes span a range... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.